Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6696495 | 7371461 | I | 6696495-3 | 20100222 | 20100414 | 20100421 | EXP | LTI2010A00048 | LABORATORIES TAKEDA S.A. | 68 | YR | M | N | 20100420 | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6696495 | 1013567274 | PS | ACTOS | 1 | ORAL | 30 MG (30 MG, 1 IN 1 D), ORAL | D | D | 21073 | ||
| 6696495 | 1013598254 | C | METFORMIN HCL | 1 | |||||||
| 6696495 | 1013598255 | C | DAONIL (GLIBBNCLAMIDE) | 2 | |||||||
| 6696495 | 1013598256 | C | ACARBOSE | 1 | |||||||
| 6696495 | 1013598257 | C | CREATOR (ROSUVASTATIN CALCIUM) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6696495 | 1013567274 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6696495 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6696495 | HYPERTENSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6696495 | FGN |
| 6696495 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6696495 | 1013567274 | 20091124 | DAY |